The Life Sciences division is dedicated to pioneering advancements in health, biology, and biotechnology. This division invests in and develops new technologies related to pharmaceuticals, medical devices, bioinformatics, and genomics. We focus on leveraging our AI and data platforms to accelerate research and development, aiming to solve some of the most pressing challenges in human and animal health. This division embodies our commitment to long-term, impactful innovation that improves quality of life and creates significant value.
Cybatar Riovic Group Limited (16031805) is registered with the Company House for the following activities: Activities of other holding companies not elsewhere classified, Activities of venture and development capital companies, Research and experimental development on biotechnology, and Other research and experimental development on natural sciences and engineering. Cybatar Riovic Group (Pty) Ltd. (K2017/327950/07) is registered with the Companies and Intellectual Property Commission.
Cybatar Riovic Group © 2025. All Rights Reserved.
